First-line Advanced NSCLC Patients Clinical Trial
Official title:
A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients
This study includes two parts, part A is for non-squamous NSCLC and part B is for squamous NSCLC.
This study is a study of SSGJ-707 combination therapy in First-line advanced NSCLC Patients. This study includes two parts, part A is for non-squamous NSCLC and part B is for squamous NSCLC. Each part will assess the efficacy and safety of the preset several dose levels of SSGJ-707 in advanced NSCLC Patients. ;